Three-Quarters of Persons in the US Population Reporting a Clinical Diagnosis of Fibromyalgia Do Not Satisfy Fibromyalgia Criteria: The 2012 National Health Interview Survey

por Walitt, Brian, Katz, Robert S., Bergman, Martin J., Wolfe, Frederick
Publicado 2016

Composite Indices Using 3 or 4 Components of the Core Data Set Have Similar Predictive Ability to Measure Disease Activity in RA: Evidence from the DANCER and REFLEX Studies

por Bergman, Martin J., Reiss, William, Chung, Carol, Wong, Pamela, Turpcu, Adam
Publicado 2013

Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials

por Keystone, Edward C, Ahmad, Harris A, Yazici, Yusuf, Bergman, Martin J
Publicado 2020

The Prevalence and Characteristics of Fibromyalgia in the 2012 National Health Interview Survey

por Walitt, Brian, Nahin, Richard L., Katz, Robert S., Bergman, Martin J., Wolfe, Frederick
Publicado 2015

Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis

por Bergman, Martin J., Elkin, Eric P., Ogale, Sarika, Kamath, Tripthi, Hamburger, Max I.
Publicado 2014

MDHAQ/RAPID3 scores in patients with osteoarthritis are similar to or higher than in patients with rheumatoid arthritis: a cross-sectional study from current routine rheumatology c...

por El-Haddad, Carlos, Castrejon, Isabel, Gibson, Kathryn A, Yazici, Yusuf, Bergman, Martin J, Pincus, Theodore
Publicado 2017

Clinical Utility and Cost Savings in Predicting Inadequate Response to Anti-TNF Therapies in Rheumatoid Arthritis

por Bergman, Martin J., Kivitz, Alan J., Pappas, Dimitrios A., Kremer, Joel M., Zhang, Lixia, Jeter, Anna, Withers, Johanna B.
Publicado 2020

Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials

por Strand, Vibeke, Lee, Eun Bong, Yazici, Yusuf, Dikranian, Ara, Wilkinson, Bethanie, Takiya, Liza, Zang, Chuanbo, Bananis, Eustratios, Bergman, Martin J.
Publicado 2018

Clinical and Economic Benefit of Achieving Disease Control in Psoriatic Arthritis and Ankylosing Spondylitis: A Retrospective Analysis from the OM1 Registry

por Bergman, Martin J., Zueger, Patrick, Patel, Jayeshkumar, Saffore, Christopher D., Topuria, Ia, Cavanaugh, Cristi, Fang, Siran, Clewell, Jerry, Ogdie, Alexis
Publicado 2022

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

por Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason
Publicado 2017